Back

Milestone Pharmaceuticals wins China approval for etripamil nasal spray, first outside US

Verifying
  • Milestone Pharmaceuticals announced China’s approval of etripamil nasal spray for PSVT.
  • China became the first market outside the United States to approve etripamil.
  • The approval was issued by China’s NMPA, the National Medical Products Administration.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Milestone Pharmaceuticals wins China approval for etripamil nasal spray, first outside US - CoinPost Terminal